A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease

NCT03093519 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: KHK6640
DRUG: Placebo

Sponsor

Kyowa Kirin Co., Ltd.